Abbott Laboratories news

   Watch this stock
Showing stories 1 - 10 of about 128   

Articles published

ABT 42.86 +0.11 (0.26%)
price chart
Abbott Labs to Sell Generic Drug Assets to Mylan
Abbott will receive about a 21% stake, or 105 million shares, of a newly formed entity that will combine Mylan's existing business and Abbott's generic pharmaceuticals business in developed markets not including the U.S. The new entity will be ...
Mylan to Buy Abbott's Generic Drug Business Outside US for $5.3 Billion  New York Times
Mylan to Add Abbott's Generic-Drug Unit, Cut Tax Rate  Bloomberg
Related articles »  
Abbott Labs' $84M insurance award in claims dispute over obesity drug upheld
The case concerns the question of who should bear the cost of the Italian government's March 2002 recall of a prescription anti-obesity drug, Meridia, that had been manufactured by Knoll Pharmaceutical Co.
Why Growth Is Coming to Abbott Laboratories Stock
Abbott Laboratories (NYSE: ABT ) markets everything from Similac baby formula to cataract surgery equipment and its restructuring itself in order to spark revenue growth.
Abbott Laboratories' (ABT) CEO, Miles White on Q2 2014 Results ...  Seeking Alpha
Earnings Expected to Increase for Abbott Laboratories  Forbes
Related articles »  
Ex-Dividend Reminder: AbbVie, Abbott Laboratories and Rouse Properties
Looking at the universe of stocks we cover at Dividend Channel, on 7/11/14, AbbVie AbbVie Inc. (NYSE: ABBV), Abbott Laboratories Abbott Laboratories (NYSE: ABT), and Rouse Properties Rouse Properties, Inc. (NYSE: RSE) will all trade ex-dividend for ...
Related articles »  
Abbott Laboratories Now #70 Largest Company, Surpassing Colgate-Palmolive
Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given company's stock.
Related articles »  
Will These EPS Estimate Cuts Hurt Abbott Laboratories (ABT) Stock Today?
"We rate ABBOTT LABORATORIES (ABT) a HOLD. The primary factors that have impacted our rating are mixed ? some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance ...
Top Stocks to Watch Today: St. Jude Medical, Abbott Laboratories, Eli Lilly ...
Let's take a quick look at four stocks -- St. Jude Medical (NYSE: STJ ) , Abbott Laboratories (NYSE: ABT ) , Eli Lilly (NYSE: LLY ) , and Pfizer (NYSE: PFE ) -- which could loom large in health care headlines this Wednesday morning.
Related articles »  
3 Keys to Watch for in Abbott Laboratories' Earnings
Abbott Labs (NYSE: ABT ) ran into tough times in the first quarter. A supplier recall in China pounded the diversified health care giant's nutritional business, sinking sales at Abbott's most important unit for the future by 4%.
Related articles »  
Abbott Labs, Fonterra Collaborate for Dairy Farm Hub in China
Abbott Laboratories (ABT - Analyst Report) announced that it has signed an agreement with New Zealand-based Fonterra Co-operative Group Ltd.
Abbott Labs to build dairy farms in China  Chicago Tribune
Abbott's 16000 Cows Are Bid for China's Nutrition Market  Bloomberg
Related articles »  
Should Dividend Investors Eject Abbott Laboratories Stock?
Dividend aristocrat Abbott Labs (NYSE: ABT ) has has a long history of rewarding income investors, but after its transformation, is it still one of the sector's top dividend stocks?